We also transfected CLL cells with siRNA targeting NF-κB-p65, which reduced CLL cell expression of NF-κB-p65, compared to that of CLL cells transfected with a non-specific siRNA (Fig. 5B). The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.